Key facts
- It has raised $880K; the latest was Grant ($130K) in Jan 2026.
- Notable investors include InnoFounder, Founders Factory, Eurostars, Food & Bio Cluster Denmark, G-Force — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Enzidia
- ·The full record, as it builds
Funding rounds
No funding rounds for Enzidia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enzidia
Developer of a biotech platform intended to accelerate enzyme engineering for industrial applications. The company's platform combines synthetic biology, high-throughput data generation, and machine learning to significantly speed up the enzyme design and optimization process, enabling researchers to develop novel biocatalysts for various bioprocesses through collaborative partnerships.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2024
- Employees
- 6
- Website
- enzidia.com/
- Ownership
- Privately Held (backing)
Enzidia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enzidia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enzidia in its N-PORT filings yet. We sweep new filings monthly.